|
Lonza
ipf lung fibroblasts ![]() Ipf Lung Fibroblasts, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ipf+lung+fibroblasts/pmc07193787-102-0-7?v=Lonza Average 90 stars, based on 1 article reviews
ipf lung fibroblasts - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Lonza
disease human lung fibroblasts dhlf-ipf ![]() Disease Human Lung Fibroblasts Dhlf Ipf, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ipf+lung+fibroblasts/pm37710230-73-15-19?v=Lonza Average 90 stars, based on 1 article reviews
disease human lung fibroblasts dhlf-ipf - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
BioIVT Inc
diseased ipf lung fibroblasts ![]() Diseased Ipf Lung Fibroblasts, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ipf+lung+fibroblasts/pmc11272128-159-13-20?v=BioIVT+Inc Average 90 stars, based on 1 article reviews
diseased ipf lung fibroblasts - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
BioIVT Inc
primary human ipf lung parenchymal fibroblasts ![]() Primary Human Ipf Lung Parenchymal Fibroblasts, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ipf+lung+fibroblasts/bio_rxiv__2020__07__20__207555-199-6-13?v=BioIVT+Inc Average 90 stars, based on 1 article reviews
primary human ipf lung parenchymal fibroblasts - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Lonza
cryopreserved ampules of diseased human lung fibroblasts, idiopathic pulmonary fibrosis (dhlf-ipf) ![]() Cryopreserved Ampules Of Diseased Human Lung Fibroblasts, Idiopathic Pulmonary Fibrosis (Dhlf Ipf), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ipf+lung+fibroblasts/pmc09103910-123-1-21?v=Lonza Average 90 stars, based on 1 article reviews
cryopreserved ampules of diseased human lung fibroblasts, idiopathic pulmonary fibrosis (dhlf-ipf) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Lonza
ll29 cells (lung fibroblasts from ipf patient) ![]() Ll29 Cells (Lung Fibroblasts From Ipf Patient), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ipf+lung+fibroblasts/pm38789791-35-0-26?v=Lonza Average 90 stars, based on 1 article reviews
ll29 cells (lung fibroblasts from ipf patient) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Cryopreserved ampule of Diseased Human Lung Fibroblasts, Idiopathic Pulmonary Fibrosis (DHLF-IPF) containing ≥ 500,000 cells
|
Buy from Supplier |
Image Search Results
Journal: American Journal of Respiratory Cell and Molecular Biology
Article Title: Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
doi: 10.1165/rcmb.2019-0092OC
Figure Lengend Snippet: Idiopathic pulmonary fibrosis (IPF) lung myofibroblasts demonstrate impaired dedifferentiation capacity. (A–D) Fibroblasts isolated from the lungs of healthy adults and patients with biopsy-proven IPF were evaluated for cellular senescence by qualitative (A) and quantitative (B) measurements of senescence-associated β-gal activity, expression of the senescence markers by Western blotting (C), and densitometric analyses (D). Scale bars: 100 μm. *P < 0.05 and ****P < 0.0001 as compared with adult healthy lungs, using Student’s two-tailed t-test. (E–J) Cells were serum starved for 16 hours, treated with TGF-β (2 ng/ml) for 48 hours (Day 0), and then treated with 0% or 20% FBS for 5 days. Expression of α-SMA, MyoD, and GAPDH was assessed by Western blotting in fibroblasts isolated from adult healthy lungs (E) and from IPF lungs (H). (F–J) α-SMA and MyoD were quantified by densitometric analyses for adult healthy fibroblasts (F and G) and for IPF fibroblasts (I and J). **P < 0.01 and ****P < 0.0001 as compared with Day 0, using Student’s two-tailed t-test. All values represent means ± SEM; n = 3 biological replicates from 3 independent experiments.
Article Snippet:
Techniques: Isolation, Activity Assay, Expressing, Western Blot, Two Tailed Test
Journal: American Journal of Respiratory Cell and Molecular Biology
Article Title: Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
doi: 10.1165/rcmb.2019-0092OC
Figure Lengend Snippet: Impaired dedifferentiation in IPF fibroblasts is associated with apoptosis resistance. Adult healthy and IPF lung fibroblasts were serum starved for 16 hours, treated with TGF-β (2 ng/ml) for 48 hours (Day 0), and then treated with 0% or 20% FBS for 5 days. Cells were treated with vehicle or staurosporine (300 nM) for 8 hours, and Caspase 3 activity was assessed (A). (B–D) Expression of cPARP, cCaspase 3, and GAPDH was assessed by Western blotting (B and C) and densitometric analyses (D). Values represent means ± SEM; n = 3 biological replicates; **P < 0.01 and ***P < 0.001 using Student’s two-tailed t test.
Article Snippet:
Techniques: Activity Assay, Expressing, Western Blot, Two Tailed Test
Journal: American Journal of Respiratory Cell and Molecular Biology
Article Title: Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
doi: 10.1165/rcmb.2019-0092OC
Figure Lengend Snippet: MyoD is upregulated in IPF lung myofibroblasts, and genetic targeting restores apoptosis susceptibility. (A) IPF lung tissue sections were analyzed by immunohistochemistry for expression of MyoD. Scale bars: 100 μm. (B and C) Adult healthy and IPF lung fibroblasts were evaluated for protein expression of MyoD by Western blotting (B) and densitometric analyses (C). (D and E) IPF fibroblasts were transfected with MyoD siRNA. Downregulation of MyoD was confirmed by Western blotting (D) and caspase activity of transfected cells was assessed (E). Values represent means ± SEM; n = 3 biological replicates; **P < 0.01 and ****P < 0.0001 using Student’s two-tailed t test. NT = nontargeting siRNA.
Article Snippet:
Techniques: Immunohistochemistry, Expressing, Western Blot, Transfection, Activity Assay, Two Tailed Test
Journal: Aging (Albany NY)
Article Title: Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells
doi: 10.18632/aging.205994
Figure Lengend Snippet: DNA damage is a hallmark of commercial primary IPF fibroblasts in vitro , but not Cdkn2a /p16 ink4a expression or a fibrotic secretome . ( A ) Primary NHLF and IPF cells ( n = 3 different donors, each with 2 technical replicates) were cultured at the same density overnight on standard tissue culture plates in low-serum growth medium and were subsequently fixed. Immunocytochemistry was performed to fluorescently label nuclei (blue) and p21 Waf1/Cip1 (orange). Images were acquired with a 40X water objective using an Operetta High Content Screening instrument and intensity of nuclear p21 Waf1/Cip1 was quantified and calculated as a positive percentage of each population. ( B ) NHLF and IPF cells were treated and imaged as in ( A ), and immunocytochemistry was performed to fluorescently label nuclei (blue) and DNA damage via nuclear γH2A.X (Ser139) foci (orange). The number of nuclear foci per cell was quantified and cells with one or more were reported as positive. ( C ) Following overnight culture in standard tissue culture plates, NHLF and IPF cells were lysed, and qPCR was performed. Expression of senescence and fibrosis-related matrix and secreted factor genes was assessed, and data were normalized to β2m housekeeper expression using the 2 −ΔΔCt method versus NHLF cells. ( D ) Following overnight culture as in ( C ), cell culture supernatants were collected and assayed for determination of the concentration of common fibrosis-related secreted proteins by MSD kits. Statistical analysis was performed using an unpaired t -test ( A , B ) or a two-way ANOVA with a Bonferroni post-test ( C , D ) in GraphPad Prism: * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent standard error of the mean (SEM).
Article Snippet: Primary normal human lung fibroblasts (NHLF) were purchased from Lonza and ATCC, and
Techniques: In Vitro, Expressing, Cell Culture, Immunocytochemistry, High Content Screening, Concentration Assay
Journal: Aging (Albany NY)
Article Title: Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells
doi: 10.18632/aging.205994
Figure Lengend Snippet: Summary of in vitro and ex vivo systems to mimic alveolar epithelial and fibroblast damage and dysfunction in the IPF lung. While IPF fibroblasts and bleomycin treated NHLFs exhibit some hallmarks of senescence, these cells do not appear to demonstrate a phenotype of Cdkn2a /p16 ink4a expression, ECM deposition, or secretion of fibrotic mediators such as TIMP1. Rather, the SASP of senescent, aberrant epithelial cells drives a fibrotic phenotype in NHLFs that is consistent with progressive fibrosis. Development of senolytic agents presents an opportunity for therapeutic impact early in disease pathogenesis and with an orthogonal mechanism than the fibroblast targeting standard of care, Nintedanib. Image created with https://www.biorender.com/ .
Article Snippet: Primary normal human lung fibroblasts (NHLF) were purchased from Lonza and ATCC, and
Techniques: In Vitro, Ex Vivo, Expressing